PPARA and type 2 diabetes mellitus: To summarize, ICS II exerts potent anti-T2DM effect with anti-oxidative and anti-inflammatory properties, at least partly by targeting PPARα/γ-mediated ROS/NF-κB/IRS1 signaling pathway.